Prevalence and burden of headache and migraine in Germany
- PMID: 19125877
- DOI: 10.1111/j.1526-4610.2008.01263.x
Prevalence and burden of headache and migraine in Germany
Abstract
Objective: To determine prevalence and burden of headache and migraine in the general population in Germany including patterns of healthcare and medication use.
Methods: Telephone interviews were conducted on a representative sample of the general population in Germany aged >or=18 years (n = 7341). Migraine was diagnosed according to the International Headache Society criteria.
Results: One-year prevalence was: headache 60.2%, migraine 10.6%, nonmigrainous severe headache 24.7% (women 66.6%, 15.6%, and 27.1%; men 53.0%, 5.3%, and 22.2%). Approximately 60% of headache sufferers reported severe headaches, 30% of which were migrainous. Migraineurs reported more often frequent headaches, disability, use of analgesics, and medical consultation than individuals with nonmigrainous severe headaches. Only 42% of migraineurs had consulted a physician and the majority relied exclusively on over-the-counter medication.
Conclusion: Migraine accounts for a great part of the healthcare impact of headaches in Germany. However, the majority of migraineurs do not seek medical care and may not be optimally treated.
Similar articles
-
Prevalence of migraine in patients with a history of self-reported or physician-diagnosed "sinus" headache.Arch Intern Med. 2004 Sep 13;164(16):1769-72. doi: 10.1001/archinte.164.16.1769. Arch Intern Med. 2004. PMID: 15364670
-
Migrainous vertigo: prevalence and impact on quality of life.Neurology. 2006 Sep 26;67(6):1028-33. doi: 10.1212/01.wnl.0000237539.09942.06. Neurology. 2006. PMID: 17000973
-
Attitudes and burden of disease among self-considered migraineurs--a nation-wide population-based survey in Sweden.Cephalalgia. 2004 Jun;24(6):455-65. doi: 10.1111/j.1468-2982.2004.00703.x. Cephalalgia. 2004. PMID: 15154855
-
The prevalence, impact, and treatment of migraine and severe headaches in the United States: a review of statistics from national surveillance studies.Headache. 2013 Mar;53(3):427-36. doi: 10.1111/head.12074. Epub 2013 Mar 7. Headache. 2013. PMID: 23470015 Review.
-
Migraine prevalence. A review of population-based studies.Neurology. 1994 Jun;44(6 Suppl 4):S17-23. Neurology. 1994. PMID: 8008222 Review.
Cited by
-
A stated preference survey to explore patient preferences for novel preventive migraine treatments.Headache. 2022 Oct;62(9):1187-1197. doi: 10.1111/head.14386. Epub 2022 Sep 1. Headache. 2022. PMID: 36047857 Free PMC article. Review.
-
Patients' perspective on the burden of migraine in Europe: a cross-sectional analysis of survey data in France, Germany, Italy, Spain, and the United Kingdom.J Headache Pain. 2018 Sep 10;19(1):82. doi: 10.1186/s10194-018-0907-6. J Headache Pain. 2018. PMID: 30203163 Free PMC article.
-
Population-based pace study: lifetime and past-year prevalence of headache in adults.Neurol Sci. 2010 Jun;31 Suppl 1:S145-7. doi: 10.1007/s10072-010-0311-8. Neurol Sci. 2010. PMID: 20464607
-
Prevalence of Migraine Headache in Saudi Arabia: A Systematic Review and Meta-Analysis.Cureus. 2023 Apr 14;15(4):e37560. doi: 10.7759/cureus.37560. eCollection 2023 Apr. Cureus. 2023. PMID: 37193445 Free PMC article. Review.
-
Sumatriptan (rectal route of administration) for acute migraine attacks in adults.Cochrane Database Syst Rev. 2012 Feb 15;2012(2):CD009664. doi: 10.1002/14651858.CD009664. Cochrane Database Syst Rev. 2012. PMID: 22336868 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical